| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 721004 | 82946 | FOLINATO CALCICO HIKMA 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | FOLINATO CALCICO HIKMA 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 5 ml | 50 mg inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82946/82946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82946/82946_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2018-09-19 | 1 | 1 | 1 | 2018-09-19 | 2018-09-19 | 1 | 2022-04-11 | View Edit Delete | ||||||||||||
| 721008 | 82946 | FOLINATO CALCICO HIKMA 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | FOLINATO CALCICO HIKMA 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 30 ml | 300 mg inyectable 30 ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82946/82946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82946/82946_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2018-09-19 | 1 | 1 | 1 | 2018-09-19 | 2018-09-19 | 1 | 2022-04-11 | View Edit Delete | ||||||||||||
| 721623 | 83080 | TEICOPLANINA ALTAN 200 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA ALTAN 200 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83080/83080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83080/83080_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41609 | ALTAN PHARMACEUTICALS S.A. | 2018-08-08 | 1 | 1 | 1 | 2018-08-08 | 2018-08-08 | 1 | 2020-07-03 | View Edit Delete | ||||||||||||
| 721624 | 83081 | TEICOPLANINA ALTAN 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA ALTAN 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 400 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83081/83081_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83081/83081_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41609 | ALTAN PHARMACEUTICALS S.A. | 2018-08-08 | 1 | 1 | 1 | 2018-08-08 | 2018-08-08 | 1 | 2020-06-29 | View Edit Delete | ||||||||||||
| 720889 | 82911 | BORTEZOMIB STADA 2,5 MG/ML SOLUCION INYECTABLE | BORTEZOMIB STADA 2,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1,4 ml | 3,5 mg inyectable 1,4 ml | 45 | 1 | 34 | 1 vial de 1,4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82911/82911_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82911/82911_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2018-03-12 | 1 | 1 | 1 | 2018-03-12 | 2018-03-12 | 1 | 2019-03-01 | View Edit Delete | ||||||||||||
| 720521 | 1171247006 | ADYNOVI 500 UI/2 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ADYNOVI 500 UI/2 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 vial de disolvente | 500 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1171247006/1171247006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171247006/1171247006_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | TAKEDA FARMACEUTICA ESPANA S.A. | 2018-02-02 | 1 | 1 | 1 | 2018-02-03 | 2018-02-02 | 1 | 2018-06-14 | View Edit Delete | ||||||||||||
| 720522 | 1171247010 | ADYNOVI 1000 UI/2 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ADYNOVI 1000 UI/2 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 vial de disolvente | 1000 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1171247010/1171247010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171247010/1171247010_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | TAKEDA FARMACEUTICA ESPANA S.A. | 2018-02-02 | 1 | 1 | 1 | 2018-02-03 | 2018-02-02 | 1 | 2018-06-14 | View Edit Delete | ||||||||||||
| 720523 | 1171247014 | ADYNOVI 2000 UI/5 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ADYNOVI 2000 UI/5 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 vial de disolvente | 2000 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1171247014/1171247014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171247014/1171247014_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | TAKEDA FARMACEUTICA ESPANA S.A. | 2018-02-02 | 1 | 1 | 1 | 2018-02-03 | 2018-02-02 | 1 | 2018-06-14 | View Edit Delete | ||||||||||||
| 721012 | 82947 | IRABGLU 370 MBQ/ML SOLUCION INYECTABLE | IRABGLU 370 MBQ/ML SOLUCION INYECTABLE, 1 vial de 10 ml | 370 Mbq/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82947/82947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82947/82947_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27723 | INSTITUT DE RADIOFARMACIA APLICADA DE BARCELONA S.L. | 2018-03-13 | 1 | 1 | 1 | 2018-03-14 | 2018-03-13 | 1 | 2018-06-18 | View Edit Delete | ||||||||||||
| 721233 | 83007 | DOPAVIEW 222 MBQ/ML SOLUCION INYECTABLE | DOPAVIEW 222 MBQ/ML SOLUCION INYECTABLE, 1 vial de 15 ml | 222 MBq/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83007/83007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83007/83007_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41309 | ADVANCED ACCELERATOR APPLICATIONS MOLECULAR IMAGING IBERICA, S.L.U. | 2018-04-05 | 1 | 1 | 1 | 2018-04-06 | 2018-04-05 | 1 | 2019-07-05 | View Edit Delete | ||||||||||||
| 721158 | 1171241001 | ONTRUZANT 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ONTRUZANT 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171241001/1171241001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171241001/1171241001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29985 | ORGANON SALUD S.L. | 2018-04-13 | 1 | 1 | 1 | 2018-04-14 | 2018-04-13 | 1 | 2018-05-11 | View Edit Delete | ||||||||||||
| 720457 | 1151070002 | ONCASPAR 750 U/ML POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ONCASPAR 750 U/ML POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial | 750 UI/ml | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151070002/1151070002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151070002/1151070002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12731 | LABORATORIOS SERVIER S.L. | 2018-02-02 | 1 | 1 | 1 | 2018-02-03 | 2018-02-02 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 720937 | 1171257001 | HERZUMA 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | HERZUMA 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171257001/1171257001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171257001/1171257001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2018-03-16 | 1 | 1 | 1 | 2018-03-17 | 2018-03-16 | 1 | 2018-05-11 | View Edit Delete | ||||||||||||
| 721254 | 83011 | ERTAPENEM AUROVITAS 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ERTAPENEM AUROVITAS 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83011/83011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83011/83011_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2018-05-31 | 1 | 1 | 1 | 2018-05-31 | 2018-05-31 | 1 | 2020-11-11 | View Edit Delete | ||||||||||||
| 719849 | 01196001 | CANCIDAS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | CANCIDAS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01196001/01196001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01196001/01196001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2002-04-10 | 1 | 1 | 1 | 2002-04-10 | 2002-04-10 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 721350 | 1171262001 | CRYSVITA 10 MG SOLUCION INYECTABLE | CRYSVITA 10 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 10 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262001/1171262001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262001/1171262001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | KYOWA KIRIN FARMACEUTICA S.L. | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 721351 | 1171262002 | CRYSVITA 20 MG SOLUCION INYECTABLE | CRYSVITA 20 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262002/1171262002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262002/1171262002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | KYOWA KIRIN FARMACEUTICA S.L. | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 721352 | 1171262003 | CRYSVITA 30 MG SOLUCION INYECTABLE | CRYSVITA 30 MG SOLUCION INYECTABLE, 1 vial de 1 ml | 30 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171262003/1171262003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171262003/1171262003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29247 | KYOWA KIRIN FARMACEUTICA S.L. | 2018-05-11 | 1 | 1 | 1 | 2018-05-12 | 2018-05-11 | 1 | 2020-12-04 | View Edit Delete | ||||||||||||
| 720797 | 64474 | PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 10 ml | 0,5 mmol/ml inyectable 10 ml | 75 | 1 | 61 | 1 jeringa precargada de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64474/64474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64474/64474_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 72325 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2001-12-18 | 1 | 1 | 1 | 2001-12-18 | 2001-12-18 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 720847 | 64474 | PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 17 ml | 0,5 mmol/ml inyectable 17 ml | 75 | 1 | 61 | 1 jeringa precargada de 17 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64474/64474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64474/64474_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 72325 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2001-12-18 | 1 | 1 | 1 | 2001-12-18 | 2001-12-18 | 1 | 2012-01-02 | View Edit Delete |
Page 53 of 1035, showing 20 records out of 20697 total, starting on record 1041, ending on 1060